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Introduction: Myocardial scar burden (MSB), measured by delayed hyperenhancement cardiac magnetic resonance (DHE-CMR), is an independent 
predictor of mortality in severe ischemic cardiomyopathy (ICM). It is unknown if MSB impacts the protective benefit of implantable cardioverter 
defibrillators (ICDs).
Purpose: In patients with severe ICM, we sought to assess the impact of MSB and ICD implantation on outcomes in severe ICM.
Methods:  337 patients with > 70% disease in ≥1 epicardial coronary artery (77% men, median age 66 years, median LV ejection fraction [EF] 
of 22 %) underwent DHE-MRI between 2003-2007. Scar was defined as > 2 SD above normal myocardium. 94 patients underwent subsequent ICD 
implantation. Composite end-point was cardiac transplantation and all-cause mortality. 
Results:  Over a follow-up of up to 8 years, there were 107 events (102 deaths, 5 cardiac transplantations). Mean scar % ≥ 33% best predicted 
outcomes on receiver operating characteristic curve analysis. On multivariate variate analysis, age, mean scar %, diabetes, gender, and ICD 
implantation were independent predictors of outcomes (Table 1). ICD significantly improved outcomes independent of MSB (Figure 1 - log rank p = 
0.03). However, amongst patients with ICD, mean scar % ≥ 33% was still a powerful predictor of outcomes (Figure 1 - log rank p = 0.04).
Conclusions:  In patients with severe, ICD provides mortality benefit, irrespective of MSB. Nonetheless, MSB remains a powerful predictor of 
outcomes even after ICD implantation. 
